These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 24743405)

  • 1. [The role of 18F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) in liposarcoma of the chest wall].
    Yamamoto H; Sugimoto S; Miyoshi K; Yamamoto H; Soh J; Yamane M; Toyooka S; Oto T; Miyoshi S
    Kyobu Geka; 2014 Jan; 67(1):4-8. PubMed ID: 24743405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chest wall lipoma mimicking a well differentiated liposarcoma; report of two cases].
    Yamamoto J; Shimanouchi M; Ueda Y; Hashizume T; Suito T
    Kyobu Geka; 2012 Jul; 65(7):587-90. PubMed ID: 22750838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.
    Ohara M; Shigematsu H; Tsutani Y; Emi A; Masumoto N; Ozaki S; Kadoya T; Okada M
    Breast; 2013 Oct; 22(5):958-63. PubMed ID: 23756383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging.
    Zhou M; Wang C; Hu S; Zhang Y; Yao Z; Li J; Guo W; Zhang Y
    Nucl Med Commun; 2013 Jul; 34(7):694-700. PubMed ID: 23604223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of lymph node metastasis detected on 18F-FDG PET/CT for surgical planning in patients with peripheral intrahepatic cholangiocarcinoma.
    Park TG; Yu YD; Park BJ; Cheon GJ; Oh SY; Kim DS; Choe JG
    Clin Nucl Med; 2014 Jan; 39(1):1-7. PubMed ID: 24335565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Which is the best monitoring study (tumor marker, computed tomography or 18F-fluoro-2-deoxy-D-glucose positron emission tomography) to evaluate efficacy of chemotherapy on unresectable pancreatic cancer ?].
    Kobayashi N; Fujita K; Fujisawa T; Takahashi H; Yoneda M; Abe Y; Inamori M; Kirikoshi H; Kubota K; Saito S; Nakajima A
    Gan To Kagaku Ryoho; 2008 Jan; 35(1):65-70. PubMed ID: 18195530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
    Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma.
    Kim BH; Kim SJ; Kim H; Jeon YK; Kim SS; Kim IJ; Kim YK
    Nucl Med Commun; 2013 Sep; 34(9):868-76. PubMed ID: 23797273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of combined BI-RADS assessment using mammography and sonography for evaluation of incidental hypermetabolic lesions in the breast on 18F-FDG PET-CT.
    Lim S; Lee EH; Park JM; Chang YW; Kim HH; Jeong SH
    Acta Radiol; 2013 Dec; 54(10):1117-24. PubMed ID: 23864064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-fluorodeoxyglucose--positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancer.
    Mertens LS; Mir MC; Scott AM; Lee ST; Fioole-Bruining A; Vegt E; Vogel WV; Manecksha R; Bolton D; Davis ID; Horenblas S; van Rhijn BW; Lawrentschuk N
    Urology; 2014 Feb; 83(2):393-8. PubMed ID: 24468513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental-site trophoblastic tumor and fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography.
    Çerçi SS; Erdemoglu E; Bozkurt KK; Yalçn Y; Erdemoglu E
    Hell J Nucl Med; 2015; 18(3):264-7. PubMed ID: 26574698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET/CT imaging of multiple myxofibrosarcoma in left upper abdomen and chest wall.
    Yi C; Wang X; Shi X; Zhang X; Chen Z
    Nuklearmedizin; 2012; 51(6):N53-4. PubMed ID: 23250511
    [No Abstract]   [Full Text] [Related]  

  • 16. Prediction of treatment outcomes in patients with chest wall sarcoma: evaluation with PET/CT.
    Nishiyama Y; Tateishi U; Kawai A; Chuman H; Nakatani F; Miyake M; Terauchi T; Inoue T; Kim EE
    Jpn J Clin Oncol; 2012 Oct; 42(10):912-8. PubMed ID: 22850222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic pitfalls in the preoperative 18F-FDG PET/CT evaluation of a case of giant malignant solitary fibrous tumor of the pleura.
    Lococo F; Rapicetta C; Ricchetti T; Cavazza A; Filice A; Treglia G; Tenconi S; Paci M; Sgarbi G
    Rev Esp Med Nucl Imagen Mol; 2014; 33(2):109-11. PubMed ID: 24079956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between 18F-FDG-uptake and in vitro chemosensitivity of cisplatin in head and neck cancer.
    Suzuki H; Nishio M; Hanai N; Hirakawa H; Tamaki T; Hasegawa Y
    Anticancer Res; 2015 Feb; 35(2):1009-16. PubMed ID: 25667488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG PET/CT and MR imaging of CD34-negative soft-tissue solitary fibrous tumor with NAB2-STAT6 fusion gene.
    Nishio J; Iwasaki H; Aoki M; Nabeshima K; Naito M
    Anticancer Res; 2015 Feb; 35(2):967-71. PubMed ID: 25667482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Histologic Subtype and FNCLCC Grade by SUVmax Measured on
    Li CP; Liu DN; Zhou NN; Tian XY; Wang Z; Liu BN; Hao CY
    Contrast Media Mol Imaging; 2021; 2021():7191363. PubMed ID: 33505228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.